Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Celestica (CLS) Research & Development (2024 - 2025)

Celestica (CLS) has disclosed Research & Development for 2 consecutive years, with $30.2 million as the latest value for Q4 2025.

  • Quarterly Research & Development rose 29.06% to $30.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $118.2 million through Dec 2025, up 51.54% year-over-year, with the annual reading at $118.2 million for FY2025, 51.54% up from the prior year.
  • Research & Development for Q4 2025 was $30.2 million at Celestica, down from $36.4 million in the prior quarter.
  • The five-year high for Research & Development was $36.4 million in Q3 2025, with the low at $16.5 million in Q1 2024.